Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization

Rhea-AI Summary

Waters Corporation introduces HPLC CONNECT software, facilitating seamless connectivity between liquid chromatography systems and multi-angle light-scattering instruments for improved efficiency and data confidence in characterizing large molecules. The software simplifies the precise characterization of complex molecules essential for developing biologic drugs, including antibody drug conjugates, other protein conjugates, and gene therapies. Waters aims to enhance ease-of-use and accuracy in SEC-MALS analyses for critical biopharmaceutical innovations.

Biopharmaceutical Analyst

The integration of Waters Corporation's HPLC CONNECT software with multi-angle light-scattering instruments marks a significant advancement in the biopharmaceutical industry's analytical capabilities. This innovation addresses a critical need for precise characterization of large molecules, which is essential in the development of complex biologic drugs. The software's ability to streamline the data acquisition process and reduce human error can potentially lead to more rapid and reliable drug development cycles.

From a biopharmaceutical perspective, the ability to accurately characterize antibody drug conjugates and gene therapies is paramount, given their complexity and the stringent regulatory requirements for these products. The unified interface of HPLC CONNECT software could improve the reproducibility of analytical results, which is a key factor in regulatory submissions and the approval process for new biologic drugs.

Healthcare Technology Analyst

The announcement by Waters Corporation signifies a technological leap in laboratory efficiency and data management. The HPLC CONNECT software's unified interface is a notable development, as it allows for a more integrated and automated workflow. This could translate into cost savings for laboratories by reducing the time and labor traditionally required for complex molecular characterizations.

In terms of market impact, Waters Corporation's move to enhance connectivity and efficiency in biologic drug development could strengthen its competitive position. Laboratories and research institutions might favor Waters' integrated solutions, potentially leading to increased market share and revenue growth for the company.

Market Research Analyst

The biopharmaceutical sector is rapidly growing, with a strong focus on the development of biologics and gene therapies. The introduction of HPLC CONNECT software by Waters Corporation aligns with this growth by providing a tool that could improve the efficiency of research and development within this sector. As the demand for advanced analytical tools increases, Waters' new software may become a critical component in the laboratories of biopharmaceutical companies.

Furthermore, the adoption of this technology could set a new industry standard for analytical processes. The ability to control and monitor various HPLC modules from a single dashboard could become a benchmark for laboratory practices, influencing the expectations and purchasing decisions of stakeholders within the industry.

News Summary:

• Waters now enables seamless connectivity between its liquid chromatography (LC) systems and multi-angle light-scattering instruments (MALS) for improved ease-of-use, efficiency, and data confidence in characterizing large molecules.
• HPLC CONNECT™ software accelerates precise characterization of complex molecules for the development of biologic drugs, including antibody drug conjugates, other complex protein conjugates, and gene therapies.
• Unified interface enables single point of control and data collection, eliminating manual processes to help reduce human error and deliver high certainty in the data generated during acquisition and post-acquisition for analysis.

SAN DIEGO, Feb. 26, 2024 /PRNewswire/ -- Pittcon 2024 – Waters Corporation (NYSE:WAT) announced HPLC CONNECT software, an all-in-one software platform that enables full digital synchronization between Waters high- and ultra-performance liquid chromatography (HPLC/UPLC) systems and multi-angle light-scattering instruments (MALS) from its Wyatt Technology™ portfolio. The software delivers ease-of-use, greater efficiency, and higher confidence for scientists performing size exclusion chromatography and MALS (SEC-MALS) analyses for complex and critical biopharmaceutical innovations, including antibody drug conjugates, other complex protein conjugates, and gene therapies.

HPLC CONNECT software greatly simplifies characterization of large molecules – a critical step in developing biologics.

"Drug development scientists today are working with novel modalities that require advanced and comprehensive measurements for the development of new and potentially life-saving biologic drugs," said Fraser McLeod, Vice President, General Manager, QA/QC and Wyatt Technology, Waters Corporation. "The team delivered this product integration ahead of schedule to greatly simplify the characterization of complex molecules – a critical step in developing biologics. Waters HPLC CONNECT software removes a significant amount of labor, reduces risk of human error, and delivers unmatched confidence in the data generated during analysis."

HPLC CONNECT software supports select Waters™ LC systems including the ACQUITY™ Premier, Arc Premier, and Arc Systems. The software enables users to control and monitor HPLC modules including pumps, column ovens, UV detectors, and autosamplers from a single dashboard view.

Waters offers a full line of SEC columns optimized for separation of biomolecules by size, ideal for monoclonal antibodies, proteins, peptides, and other biologics.

Waters HPLC CONNECT software is now available globally.

Additional Resources

• Learn more about Waters HPLC CONNECT software
• Learn about the full line of Waters SEC Columns
• Follow and connect with Waters via LinkedIn, Twitter, and Facebook

About Waters Corporation (www.waters.com)

Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. With approximately 8,000 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.

Waters, HPLC CONNECT, Wyatt Technology, and ACQUITY are trademarks of Waters Technologies Corporation.

Contact:

Janice Foley
Senior Public Relations Manager
Waters Corporation
janice_foley@waters.com
+1.617.823.5555

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/waters-announces-seamless-hplcuplc-data-bridge-for-light-scattering-integrating-essential-instruments-for-large-molecule-characterization-302070391.html

SOURCE Waters Corporation

What software platform was announced by Waters Corporation for seamless connectivity between liquid chromatography systems and multi-angle light-scattering instruments?

Waters Corporation announced the HPLC CONNECT software.

What types of molecules can be characterized using the HPLC CONNECT software?

The software facilitates the characterization of large molecules, including antibody drug conjugates, other complex protein conjugates, and gene therapies.

Which LC systems are supported by the HPLC CONNECT software?

The software supports select Waters LC systems such as the ACQUITY Premier, Arc Premier, and Arc Systems.

What is the key benefit of using the HPLC CONNECT software for scientists?

The software simplifies the characterization of complex molecules, reducing labor, minimizing human error, and enhancing data confidence during analysis.

Where is the Waters HPLC CONNECT software available?

The Waters HPLC CONNECT software is now available globally.